An underground market for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.
Investigational Drug Gaining Traction Online
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are urged to message these accounts directly for source information, while also obtaining promotional offers.
Thriving Commerce on Social Networks
Additionally, a flourishing market exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors promote the substance there before redirecting customers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Professionals Voice Concerns
However, doctors and chemists have warned that the distribution of what remains an unlicensed drug in the UK is worrisome and could lead to individuals injecting products of unknown origin.
Several experts said the popularity for the experimental drug could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the British medical regulations.
Some content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach medicines, advertising, and customer regulations, potentially leading to fines, legal action or imprisonment.
Platform Reaction and Content Removal
According to TikTok, the service has removed violative content and banned associated hashtags and search suggestions. The organization said it was dedicated to maintaining the platform safe and allocating resources in strengthening enforcement strategies.
Online Marketplace Operations
Research also discovered communities with up to 9,000 participants selling the experimental drug using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of users, filled with photos of weight loss, positive testimonials and step-by-step guides for preparing or administering at residence.
After minutes of joining one community, a seller shared contact information, where most transactions occur. The vendor sent an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about weight, health issues or previous experience.
Item Details and Pricing
Within these communities, messages display dark colored parcels with postal service stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When asked how long a injector should last, sellers give contradictory answers ranging from a several days to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for the messaging service stated it actively monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are administering materials they can’t verify. Although the science behind retatrutide is sound, these digital versions may not contain what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of an online medical service connected the increase in interest to current price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.
Her staff has previously encountered patients injured by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet authorized … may subject users to potentially serious health risks”.
